P, L., S, Z., BY, C., B, C., Y, J., X, L., . . . L, W. (2026). Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia. Science translational medicine, 18(848), eadv8951. https://doi.org/10.1126/scitranslmed.adv8951
Chicago Style (17th ed.) CitationP, Liu, et al. "Targeting RBPMS Selectively Eliminates FOXO1-mediated Stem Cell Signatures in Mouse Models of Acute Myeloid Leukemia." Science Translational Medicine 18, no. 848 (2026): eadv8951. https://doi.org/10.1126/scitranslmed.adv8951.
MLA (9th ed.) CitationP, Liu, et al. "Targeting RBPMS Selectively Eliminates FOXO1-mediated Stem Cell Signatures in Mouse Models of Acute Myeloid Leukemia." Science Translational Medicine, vol. 18, no. 848, 2026, p. eadv8951, https://doi.org/10.1126/scitranslmed.adv8951.